Regulated cell death pathways in cardiomyopathy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.nature.com/articles/s41401-023-01068-9.pdf
Reference222 articles.
1. McKenna WJ, Maron BJ, Thiene G. Classification, epidemiology, and global burden of cardiomyopathies. Circ Res. 2017;121:722–30.
2. Lannou S, Mansencal N, Couchoud C, Lassalle M, Dubourg O, Stengel B, et al. The Public Health Burden of Cardiomyopathies: insights from a Nationwide Inpatient Study. J Clin Med. 2020;9:920–33.
3. Yamada T, Nomura S. Recent findings related to cardiomyopathy and genetics. Int J Mol Sci. 2021;22:15222–34.
4. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.
5. Sorajja P, Pedersen WA, Bae R, Lesser JR, Jay D, Lin D, et al. First experience with percutaneous mitral valve plication as primary therapy for symptomatic obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2016;67:2811–8.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death;Cardiovascular Toxicology;2024-02-06
2. Regulated Cell Death in Endometriosis;Biomolecules;2024-01-23
3. Integrated bioinformatics and experiment revealed that cuproptosis is the potential common pathogenesis of three kinds of primary cardiomyopathy;Aging;2023-12-11
4. Therapeutic Approaches Targeting Ferroptosis in Cardiomyopathy;Cardiovascular Drugs and Therapy;2023-11-06
5. Leashing Ferroptosis in Myocardial Ischemia/Reperfusion Injury: Role of the YAP/NEDD4L/ACSL4 Pathway, Knowledge Gaps, and Potential Therapeutic Application;Canadian Journal of Cardiology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3